n CME : Your SA Journal of CPD - Botulinum toxin for the treatment of migraine and other primary headache disorders : main article
|Article Title||Botulinum toxin for the treatment of migraine and other primary headache disorders : main article|
|© Publisher:||Health and Medical Publishing Group (HMPG)|
|Journal||CME : Your SA Journal of CPD|
|Author||Johan A. Smuts|
|Publication Date||Jul 2005|
|Pages||331 - 333|
Botulinum toxin offers a new treatment option for patients suffering from chronic pain syndromes including migraine and tension-type headache. <br>Headache patients often suffer greatly as a result of sideeffects of the drugs used as prophylactic agents. These can include dizziness, fatigue, weight gain, hair loss and loss of libido. BoNTA does not cause any of these sideeffects and to date no organic damage or allergic complications have been reported. <br>The long duration of action also has the added benefit that patients do not need to take medication on a daily basis. <br>These factors make this a treatment with a high safety profile and high patient acceptability. <br>In the treatment of headache there are opinion differences on dosages, areas of injection and patient selection. Comparative studies with standard treatments are still needed. <br>Currently therefore the use of BoNTA in the treatment of headache is only justified after all standard therapeutic procedures have been exhausted and only after evaluation in specialist centres.
Article metrics loading...